tility of vessel-sealing systems in reducing serous drainage after axillary dissecton for breast surgery : A prospective randomized study
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000013034
- Lead Sponsor
- Tokai University school of medicine Department of Breast Endocrine Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Planned to breast reconstruction surgery 2) Post sentinel node biopsy 3) Patients who take anticoagulants or antiplatelet agents 4) Patients with severe hepatic disease. 5) Patients with severe kidney disease. 6) Pregnant and women who may be pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of removing drain after surgery
- Secondary Outcome Measures
Name Time Method Total drainage volume Intraoperative blood loss Safety: incidence of postoperative surgical complications
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie reduced serous drainage with vessel-sealing systems in axillary dissection for breast cancer?
How effective are vessel-sealing systems compared to traditional electrocautery in minimizing serous drainage after axillary dissection for breast cancer?
Which biomarkers predict optimal outcomes with vessel-sealing systems in axillary dissection for breast cancer subtypes?
What are the potential adverse events associated with vessel-sealing systems in axillary dissection and their management strategies?
How do different vessel-sealing devices (e.g., LigaSure, ENSEAL) compare in reducing serous drainage after breast cancer surgery?